从Aframemum melegueta解读固酶-5抑制剂:针对勃起功能障碍的计算模型
1Phyto-medicine and Computational Biology Lab, Department of Biochemistry, Adekunle Ajasin University, Akungba-Akoko, Ondo State Nigeria.
In silico pharmacology
|November 11, 2024
概括
研究人员选了来自Aframomum melegueta的化合物用于治疗勃起功能障碍. 九种化合物显示出作为固酶-5 (PDE-5) 抑制剂的潜力,其中一种化合物表现出与西尔德纳菲尔相当的稳定性.
科学领域:
- 计算化学是一种计算化学.
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 勃起功能障碍 (ED) 影响全球夫妇,需要新的治疗策略.
- 基化酶-5 (PDE-5) 抑制剂是ED管理的关键.
- Aframomum melegueta被探索其潜在的生物活性化合物.
研究的目的:
- 几乎选来自Aframomum melegueta的生物活性化合物对PDE-5进行选.
- 为了确定潜在的ED治疗,强大的PDE-5抑制剂.
- 通过分子动力学模拟来验证化合物.
主要方法:
- 使用施罗丁格套件对来自Aframomum melegueta的109种化合物的虚拟选.
- 对PDE-5进行对接研究.
- 使用Desmond进行100ns分子动力学 (MD) 模拟以验证化合物.
- 药解子假设和QSAR建模用于进一步的预测.
- 利宾斯基的五项规则和药物动力学参数分析.
主要成果:
- 九种化合物被预测为强大的PDE-5抑制剂.
- 1,7-bis(3,4-二基-5-甲基) -3,5-二二甲酸显示出最好的对接得分 (-11.522 kcal/mol).
- 医学药物模拟表明,化合物-PDE-5复合物的稳定性与西尔代纳菲尔相当.
- 所有被击中化合物都遵守了利宾斯基规则和药理动力学参数.
结论:
- 来自Aframomum melegueta的9个分子被预测为有效的PDE-5抗剂.
- 化合物,1,7-bis(3,4-二-5-甲基) -3,5-二乙酸,显示出对ED管理的承诺.
- 需要进一步的实验验证,以证实这些发现.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
426
00:05In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
13.9K
相关概念视频
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
129
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
129
01:20Pharmacokinetic Models: Overview
592
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
592
01:28Structure-Activity Relationships and Drug Design
597
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
597
01:21Mechanistic Models: Overview of Compartment Models
68
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
68
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.7K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.7K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
45
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
45